Beijing Dongshengzihang Culture Development Co., Ltd. – Trademark Portfolio

Entity Type: 99

Beijing Dongshengzihang Culture Development Co., Ltd. holds 1 U.S. trademark filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 25 (Clothing) — 1 filings in this category. Currently, 1 trademark is registered. Notable registered marks include VIA MONTEBELLO 52. The owner is based in Beijing.

Room 485, 4th Floor, People's Daily Printing Plant

Wangsiying Township, Chaoyang District

Beijing 100023 , CN

1 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

Trademark Classifications

Beijing Dongshengzihang Culture Development Co., Ltd.'s trademark portfolio spans 1 Nice Classification class, reflecting the scope of goods and services protected under their brand portfolio.

25
Clothing (1 filing)

Clothing, footwear, headgear

Frequently Asked Questions

How many trademarks does Beijing Dongshengzihang Culture Development Co., Ltd. have?

Beijing Dongshengzihang Culture Development Co., Ltd. has 1 U.S. trademark filed with the USPTO. Of these, 1 registered.

What trademark classes does Beijing Dongshengzihang Culture Development Co., Ltd. file in?

Beijing Dongshengzihang Culture Development Co., Ltd. files trademarks across 1 Nice Classification class. The most active classes are Class 25 (Clothing). Class 25 covers clothing, footwear, headgear.

What are Beijing Dongshengzihang Culture Development Co., Ltd.'s most well-known trademarks?

Beijing Dongshengzihang Culture Development Co., Ltd.'s registered trademark portfolio includes well-known marks such as VIA MONTEBELLO 52. These are among 1 currently registered trademark in the portfolio.

What is Beijing Dongshengzihang Culture Development Co., Ltd.'s trademark registration success rate?

Beijing Dongshengzihang Culture Development Co., Ltd. has a 100% trademark registration rate, with 1 out of 1 resolved applications resulting in successful registration. Currently, 0 applications are pending review.